Beck Z et al. Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration.. (1998) LEUKEMIA & LYMPHOMA 1042-8194 1029-2403 30 3-4 293-306,
1193949
Szakcikk (Folyóiratcikk) | Tudományos[1193949]
Ye Yin et al. c-myb is involved in CML progression and is a therapeutic target in the zebrafish CML model. (2022) ANIMAL MODELS AND EXPERIMENTAL MEDICINE 2096-5451 2576-2095
Chandran Ramachandran Krishna et al. Differential gene expression changes and their implication on the disease progression in patients with Chronic Myeloid Leukemia. (2019) BLOOD CELLS MOLECULES AND DISEASES 1079-9796 1096-0961 77 51-60
Cortiguera Maria G et al. MYC as therapeutic target in leukemia and lymphoma. (2015) BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY 1179-9889 1179-9889 5 75-91
Albajar M et al. MYC in chronic myeloid leukemia: Induction of aberrant DNA synthesis and association with poor response to imatinib. (2011) MOLECULAR CANCER RESEARCH 1541-7786 1557-3125 9 5 p. 564-576
Fioretos T et al. Chronic Myeloid Leukemia. (2010) Megjelent: Cancer Cytogenetics: Chromosomal and Molecular Genetic Abberations of Tumor Cells, 3rd Edition pp. 179-207
Hashino S et al. Clonal switch of leukemic myeloblasts after chemotherapy in a patient with chronic myeloproliferative disorder. (2009) ACTA HAEMATOLOGICA 0001-5792 1421-9662 122 1 p. 29-30
Beyer V et al. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: Report on a cohort of 12 patients and review of 105 published cases. (2005) CANCER GENETICS AND CYTOGENETICS 0165-4608 1873-4456 160 2 p. 97-119
Vaque JP et al. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21(Cip1) pathway. (2005) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 280 2 1112-1122
Nem besorolt (Folyóiratcikk) | Tudományos[25758366] [Admin láttamozott]
Ceballos E et al. Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes. (2005) ONCOGENE 0950-9232 1476-5594 24 28 p. 4559-4571
Ness S. Myb protein specificity: Evidence of a context-specific transcription factor code. (2003) BLOOD CELLS MOLECULES AND DISEASES 1079-9796 1096-0961 31 2 p. 192-200
Stevens-Kroef M J et al. Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences. (2000) CANCER GENETICS AND CYTOGENETICS 0165-4608 1873-4456 116 2 p. 119-123
Ceballos E et al. c-Myc antagonizes the effect of p53 on apoptosis and p21(WAF1) transactivation in K562 leukemia cells. (2000) ONCOGENE 0950-9232 1476-5594 19 18 2194-2204
Horita M et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-x(L). (2000) JOURNAL OF EXPERIMENTAL MEDICINE 0022-1007 1540-9538 191 6 p. 977-984
Szabó J et al. Reciprocal interactions between human cytomegalovirus and human T cell leukemia-lymphoma virus type I in monocyte-derived macrophages cultured in vitro.. (1998) AIDS RESEARCH AND HUMAN RETROVIRUSES 0889-2229 1931-8405 14 8 699-709,
1085439
Szakcikk (Folyóiratcikk) | Tudományos[1085439]
Nagai S. et al. Management of Cytomegalovirus Infection in Patients with Adult T-cell Leukemia/Lymphoma.. (2009) Asia-Pacific Journal of Oncology and Hematology 1759-6637 1759-6645 1 2 p. 1
Zhang J et al. Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I encoded Tax protein. (2007) VIROLOGY 0042-6822 1096-0341 1089-862X 369 198-205
Kubota S et al. Cell-type-specific trans-activatuon of herpes simplex virus thymidine kinase promoter by the human T-cell leukemia virus type I Tax protein. (2001) DNA AND CELL BIOLOGY 1044-5498 1557-7430 20 563-568
Fujiwara H et al. Cytomegalovirus infection is not necessarily a poor prognostic factor in adult T-cell leukemia/lymphoma. (2000) JOURNAL OF MEDICAL VIROLOGY 0146-6615 1096-9071 62 2 140-143
Bacsi A et al. Placental macrophage contact potentiates the complete replicative cycle of human cytomegalovirus in syncytiotrophoblast cells: role of interleukin-8 and transforming growth factor-beta1. (1999) JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 1079-9907 1557-7465 19 1153-1160,
17296
Szakcikk (Folyóiratcikk) | Tudományos[17296]
Trinh Quang Duy et al. Roles of TGF-beta 1 in Viral Infection during Pregnancy: Research Update and Perspectives. (2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 24 7
Fakonti Georgia et al. Placental Macrophage (Hofbauer Cell) Responses to Infection During Pregnancy: A Systematic Scoping Review. (2022) FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224 12
Kovács IJ et al. Human Cytomegalovirus Isolates Differ in Multiplication and Induction of IL-8 in Epithelial Cells.. (2017) ANNALS OF VIROLOGY AND RESEARCH 2573-1122 3 1 p. 1
BÉNARD Marie-Carole Mélinda. [ Consequences of cytomegalovirus infection on the human placenta. 2014. PhD Thesis. Toulouse 3.]: Conséquences de l'infection à cytomégalovirus sur le placenta humain. 2014. PhD Thesis. Toulouse 3.. (2014)
Schleiss Mark R. Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection. (2013) CLINICAL AND DEVELOPMENTAL IMMUNOLOGY 1740-2522 1740-2530 2013
György Berencsi et al. Maternal-Fetal Infections with Human Viruses (Chapter 4). (2012) Megjelent: Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis pp. 105-169
Younes AS et al. Heterogeneous Pathways of Maternal-fetal Transmission of Human Viruses (Review). (2009) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 15 3 451-465
Kovacs IJ et al. Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. (2007) PLACENTA 0143-4004 1532-3102 28 7 620-623
Younes Saleh Ali. HEPATITIS VIRUS MARKERS OF THE POPULATION IN THE SOUTHERN PLAIN REGION OF HUNGARY; PERINATAL AND/OR TRANSPLACENTAL TRANSMISSION OF VIRUSES. (2007)
Younes SA et al. Endotoxins do not influence transplacental transmission of lymphotropic human herpesviruses and human papillomaviruses into amniotic fluid taken from healthy mothers before parturition in Hungary. (2007) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 54 3 279-303
Halwachs-Baumann G. The congenital cytomegalovirus infection: Virus-host interaction for defense and transmission. (2006) CURRENT PHARMACEUTICAL BIOTECHNOLOGY 1389-2010 1873-4316 7 4 303-312
Wang D et al. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. (2005) JOURNAL OF VIROLOGY 0022-538X 1098-5514 79 10330-10338
Reddy UM et al. Detection of viral deoxyribonucleic acid in amniotic fluids: association with fetal malformation and pregnancy abnormalities. (2005) FETAL DIAGNOSIS AND THERAPY 1015-3837 1421-9964 20 203-207
Pusztai R et al. Mother-to-fetus transmission of cytomegalovirus. A review. (2004) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 51 4 385-401
Swasdipan S et al. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. (2002) MICROBIAL PATHOGENESIS 0882-4010 1096-1208 32 2 49-60
Redman TK et al. Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages. (2002) JOURNAL OF INFECTIOUS DISEASES 0022-1899 1537-6613 185 584-590
Wu DN et al. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity. (2001) MOLECULAR AND CELLULAR ENDOCRINOLOGY 0303-7207 1872-8057 175 1-2 111-121
Szabó J et al. Differential patterns of interaction between HIV type I and HTLV type I monocyte-derived macrophages cultured in vitro: implications for in vivo coinfection with HIV type 1 and HTLV type I. (1999) AIDS RESEARCH AND HUMAN RETROVIRUSES 0889-2229 1931-8405 15 1653-1666,
1085442
Szakcikk (Folyóiratcikk) | Tudományos[1085442]
Araujo Abelardo Q.. Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection. (2020) PATHOGENS 2076-0817 9 4
Klase Z et al. Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins. (2013) VIROLOGY 0042-6822 1096-0341 1089-862X 443 1 106-112
Rola-łuszczak M et al. Serological survey for bovine immunodeficiency virus in dairy cattle from Poland. (2011) POLISH JOURNAL OF VETERINARY SCIENCES 1505-1773 2300-2557 14 4 p. 579-583
Pedroso C et al. Coinfection by HIV-1 and human lymphotropic virus type 1 in Brazilian children is strongly associated with a shorter survival time. (2011) JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (JAIDS) 1525-4135 1944-7884 57 SUPPL. 3 p. S208-S211
Smikle MF et al. A serosurvey of hepatitis B virus, hepatitis C virus, human T lymphotropic virus type-1 and syphilis in HIV-1 infected patients in Jamaica. (2003) WEST INDIAN MEDICAL JOURNAL 0043-3144 0368-1238 52 14-14
Cesaire R et al. Quantification of HTLV type I and HIV type 1 DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment. (2001) AIDS RESEARCH AND HUMAN RETROVIRUSES 0889-2229 1931-8405 17 799-805
Takahashi Y et al. OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infecton. (2001) JOURNAL OF VIROLOGY 0022-538X 1098-5514 75 6748-6757
Campbell MS et al. Mitotic chekpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase. (2001) JOURNAL OF CELL SCIENCE 0021-9533 1477-9137 114 953-963
Brites C et al. Co-infection with HTLV-I is associated with a shorter survival time for HIV-1 infected patients in Bahia, Brazil. (2001) AIDS 0269-9370 1473-5571 15 2053-2055
Szabó J et al. Role of interleukin 8 and transforming growth factor-ß1 in enhancement of human cytomegalovirus replication by human T cell leukemia-lymphoma virus type I in macrophages coinfected with both viruses.. (1999) JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 1079-9907 1557-7465 19 209-217,
1085441
Szakcikk (Folyóiratcikk) | Tudományos[1085441]
Li CF et al. Competitive virus and host RNAs: the interplay of a hidden virus and host interaction. (2014) PROTEIN & CELL 1674-800X 1674-8018 5 5 348-356
Zhang J et al. Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I encoded Tax protein. (2007) VIROLOGY 0042-6822 1096-0341 1089-862X 369 198-205
Beck Z et al. Alterations of p53 and Rb genes and evolution of the accelerated phase of chronic myeloid leukemia.. (2000) LEUKEMIA & LYMPHOMA 1042-8194 1029-2403 38 587-597,
1085446
Szakcikk (Folyóiratcikk) | Tudományos[1085446]
Leahey Ann-Marie et al. Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma. (2021) OMAN JOURNAL OF OPHTHALMOLOGY 0974-620X 0974-7842 14 3 134-135
Bavaro Luana et al. Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update. (2019) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 20 24
Zhang Zhanglin et al. Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia. (2019) BMC CANCER 1471-2407 19 1
Perrone Salvatore et al. How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety. (2016) EXPERT OPINION ON PHARMACOTHERAPY 1465-6566 1744-7666 17 11 1517-1526
Carter BZ et al. Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells. (2015) ONCOTARGET 1949-2553 6 31 30487-30499
Soverini S et al. Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia. (2015) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2152-2650 2152-2669 15 S S120-S128
Sailaja K et al. Intronic SNPs of TP53 gene in chronic myeloid leukemia: Impact on drug response. (2012) JOURNAL OF NATURAL SCIENCE, BIOLOGY AND MEDICINE 0976-9668 2229-7707 3 2 182-185
Ernst T et al. Chronic myeloid leukemia: Clinical impact of BCR-ABL1 mutations and other lesions associated with disease progression. (2012) SEMINARS IN ONCOLOGY 0093-7754 1532-8708 39 1 58-66
Hiwase DK et al. Therapy of Advanced-Stage and Resistant Chronic Myeloid Leukemia. (2011) Megjelent: Leukemias: Principles and Practice of Therapy pp. 281-295
Rumpold H et al. Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia - is it all BCR-ABL?. (2011) CURRENT CANCER DRUG TARGETS 1568-0096 1873-5576 11 1 3-19
Jabbour E et al. Advances in the biology and therapy of patients with chronic myeloid leukaemia. (2009) BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 1521-6926 22 3 p. 395-407
Bixby D et al. The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosis. (2008) CELL CYCLE 1538-4101 1551-4005 7 971-979
Jabbour E et al. Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias. (2008) EXPERT OPINION ON INVESTIGATIONAL DRUGS 1354-3784 1744-7658 17 1127-1136
Strnad M et al. Expression of programmed cell death proteins in patients with chronic myeloid leukemia. (2008) JOURNAL OF BUON 1107-0625 2241-6293 13 403-408
Stoklosa T et al. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. (2008) CANCER RESEARCH 0008-5472 1538-7445 68 2576-2580
Sireci G et al. Anti-16-kilodalton mycobacterial protein immunglobulin m levels in helathy but purified protein derivative reactive children decrease after chemoprophylaxis. (2007) CLINICAL AND VACCINE IMMUNOLOGY 1556-6811 1556-679X 14 1231-1234
Jabbour E et al. The clinical challenge of imatinib resistance in chronic myeloid leukemia: Emerging strategies with new targeted agents. (2006) TARGETED ONCOLOGY 1776-2596 1776-260X 1 4 p. 186-196
Hosoya N et al. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. (2006) GENES CHROMOSOMES & CANCER 1045-2257 1098-2264 45 5 482-494
Nem besorolt (Folyóiratcikk) | Tudományos[25806254] [Nyilvános]
Cho D et al. Comparison of the proteosomes and antigenicities of secreted and cellular proteins produced by Mycobacterium paratuberculosis. (2006) CLINICAL AND VACCINE IMMUNOLOGY 1556-6811 1556-679X 13 10 1155-1161
Nem besorolt (Folyóiratcikk) | Tudományos[25806255] [Nyilvános]
Cho D et al. Comparison of the proteosomes and antigenicities of secreted and cellular proteins by Mycobacterium paratuberculosis. (2006) Clin. Vaccin. Immunol 13 1155-1161
Mughal TI et al. Chronicmyeloid leukemia: why does it evolve from chronic phase to blast transformation?. (2006) BIOSCIENCE 0006-3568 1525-3244 11 198-208
Bacher U et al. Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemia. (2004) LEUKEMIA & LYMPHOMA 1042-8194 1029-2403 46 357-366